Formosa Pharmaceuticals, Inc. (TPE:6838)
Taiwan · Delayed Price · Currency is TWD 27.85
-0.30 (-1.07%)
At close: Mar 2, 2026
Formosa Pharmaceuticals Market Cap
Formosa Pharmaceuticals has a market cap or net worth of 4.13 billion as of March 3, 2026. Its market cap has decreased by -19.68% in one year.
Market Cap
4.13B
Enterprise Value
2.64B
Revenue
12.16M
Ranking
n/a
PE Ratio
n/a
Stock Price
27.85
Market Cap Chart
Since October 7, 2021, Formosa Pharmaceuticals's market cap has decreased from 5.53B to 4.13B, a decrease of -25.39%. That is a compound annual growth rate of -6.43%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 3, 2026 | 4.13B | 3.60% |
| Dec 31, 2025 | 3.99B | -29.51% |
| Dec 31, 2024 | 5.65B | -15.62% |
| Dec 29, 2023 | 6.70B | 13.17% |
| Dec 30, 2022 | 5.92B | 74.66% |
| Dec 30, 2021 | 3.39B | -38.75% |
| Oct 7, 2021 | 5.53B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| UnicoCell Biomed | 5.22B |
| Pharmosa Biopharm | 5.17B |
| BioGend Therapeutics | 4.58B |
| Senhwa Biosciences | 4.48B |
| Energenesis Biomedical CO.,LTD. | 4.23B |
| Medigen Biotechnology | 4.20B |
| Intech Biopharm | 3.89B |
| ACRO Biomedical | 3.89B |